Figure 2 shows representative images of VEGFR2, EZH2, ERCC1, RAD51, and PKR staining in NSCLC cells from three patients treated with neoadjuvant chemotherapy. This evidence concerns the gene EIF2AK2 and non-small cell lung carcinoma.